Current use and developments needed for optimal design in pharmacometrics: A study performed among ddmore's european federation of pharmaceutical industries and associations members

CPT: Pharmacometrics and Systems Pharmacology

Volumn 2, Issue 6, 2013, Pages

  Mentre F ^a   Chenel, M ^b   Comets, E ^a   Grevel, J ^c   Hooker, A ^d   Karlsson, M O ^d   Lavielle, M ^e   Gueorguieva, I ^f  

^a INSERM   (France)

^b IRIS Institut de Recherches Internationales Servier   (France)

^c BAST Inc Limited   (United Kingdom)

^d UPPSALA UNIVERSITY   (Sweden)

^e INRIA   (France)

^f Global PK PD Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DESIGN; DRUG INDUSTRY; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PHARMACODYNAMICS; PHARMACOMETRICS; PRIORITY JOURNAL; REVIEW; WORKFLOW;

EID: 84881162353     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1038/psp.2013.19     Document Type: Review

References (8)

1. Mentré, F. et al. Software for optimal design in population pharmacokinetics and pharmacodynamics: a comparison. Annual Meeting of the Population Approach Group in Europe. PAGE 16 (2007) Abstract 1179 .
2. Retout, S., Duffull, S. & Mentré, F. Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs. Comput. Methods Programs Biomed. 65, 141-151 (2001). (Pubitemid 32220157)
3. Gueorguieva, I., Ogungbenro, K., Graham, G., Glatt, S. & Aarons, L. A program for individual and population optimal design for univariate and multivariate response pharmacokineticpharmacodynamic models. Comput. Methods Programs Biomed. 86, 51-61 (2007). (Pubitemid 46394511)
4. Bazzoli, C., Retout, S. & Mentré, F. Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0. Comput. Methods Programs Biomed. 98, 55-65 (2010).
5. Nyberg, J., Ueckert, S., Strömberg, E.A., Hennig, S., Karlsson, M.O. & Hooker, A.C. PopED: an extended, parallelized, nonlinear mixed effects models optimal design tool. Comput. Methods Programs Biomed. 108, 789-805 (2012).
6. Bornkamp, B. et al. Innovative approaches for designing and analyzing adaptive doseranging trials. J. Biopharm. Stat. 17, 965-995 (2007). (Pubitemid 350135825)
7. Harnisch, L. & Karlsson, M.O. Presentation of DDMoRe. Annual Meeting of the Population Approach Group in Europe. PAGE 20 (2011) Abstr 2294 .
8. Foo, L.K. & Duffull, S. Adaptive optimal design for bridging studies with an application to population pharmacokinetic studies. Pharm. Res. 29, 1530-1543 (2012).